[1]
Galeone, C., Turati, F., Nicolò, M., Parravano, M., Vujosevic, S., Bianchino, L., Sicari, E. and Lanzetta, P. 2024. Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison. Drug Target Insights. 18, 1 (Dec. 2024), 105–111. DOI:https://doi.org/10.33393/dti.2024.3213.